Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathy of Renal Significance (MGRS)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06771180
What this trial is testing

Dara-BCD for Rare MGRS

Who this might be right for
Monoclonal Gammopathy of Renal Significance (MGRS)
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06083922
What this trial is testing

CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center 20
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Not applicableUnknownNCT03629561
What this trial is testing

Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Academia Nacional de Medicina 15
Not applicableStudy completedNCT05119309
What this trial is testing

MGRS: Clinical-histological Features of a Multicenter Case Series

Who this might be right for
Monoclonal Gammopathy of Renal Significance
University of Milano Bicocca 87
Testing effectiveness (Phase 2)Looking for participantsNCT06889948
What this trial is testing

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Who this might be right for
Kidney FailureParaproteinemiasGlomerulonephritis
Helsinki University Central Hospital 30